According to GlaxoSmithKline's latest financial reports the company's current earnings are C$39.46 Billion. In 2023 the company made an earning of C$10.39 Billion, an increase over its 2022 earnings that were of C$9.56 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.